◼ Archived
Business
🔮 Archynetys predicts: fades by tomorrow — graded ✓ correct
AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion
5sources
5articles
3velocity
+0%since first seen
20d agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (5)
- 3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal Yahoo Finance · 20d ago
- Why AbbVie Is Spending $11 Billion to Buy Apogee Therapeutics—and Why the Stock Is Rising Barron's · 20d ago
- AbbVie Goes On The Offensive With $10.9 Billion Takeover Investor's Business Daily · 20d ago
- AbbVie to buy Waltham’s Apogee Therapeutics in nearly $11 billion deal The Boston Globe · 20d ago
- AbbVie sharpens immunology focus with $10.9 billion Apogee deal Reuters · 20d ago
Related trends
▲ Peaking
Business
America’s Longest Small Town: How Route 66 Became A Highway Of Dreams
Route 66 is trending as a nostalgic journey through America's heartland, drawing attention to its historic sites and local flavors.
▲ Peaking
Business
The Average Social Security Check Jumps This Much in 2027
Social Security recipients await details on 2027 cost-of-living adjustment
▲ Peaking
Business
Outrage over LA supermarket’s despicable act after shopper dropped dead in bakery aisle
▲ Peaking
Business
'Funflation' hits home: Why staying in isn't the cost-saver it used to be
'Funflation' is forcing consumers to rethink their entertainment budgets.
▲ Peaking
Business
What to Expect in Markets this Week: Inflation Data, Warsh Testimony in Congress, Bank Earnings
▲ Peaking
Business
A Study Tried to Quantify How Many LinkedIn Posts Are 100% AI. It’s a Lot
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.